Trial intelligence / Profile preview

Melatonin vs Lidocaine for Postoperative Delirium in Elderly THA Patients

NCT06768580Recruiting

Sponsor
Tanta University
Start
Jan 2025
Primary completion
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of melatonin and Lidocaine Hydrochloride Injection, without epinephrine in postoperative delirium (POD) (3 arms), sponsored by Tanta University. Primary endpoint: Incidence of Postoperative Delirium. Started Jan 2025; status: recruiting.

02

Drugs

melatoninLidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT06768580.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06768580.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call